LoginRegister
    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis dealAurobindo Pharma targets to achieve zero debt in three years sans Novartis deal
    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020
    Novartis to buy biotech firm Medicines Co for about USD 7 billion: ReportNovartis to buy biotech firm Medicines Co for about USD 7 billion: Report
    Cancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda PharmaCancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda Pharma
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard QualityCDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality
    Torrent Pharma pulled up by USFDA for significant violations at US plantTorrent Pharma pulled up by USFDA for significant violations at US plant
    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 croreCygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore
    Unichem Labs gets USFDA nod for generic version of Tenormin tabletsUnichem Labs gets USFDA nod for generic version of Tenormin tablets
    India, China spar over legacy of Sowa-Rigpa, medicinal system similar to AyurvedaIndia, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda
    Lupin launches generic Potassium Chloride for oral solution USP post USFDA nodLupin launches generic Potassium Chloride for oral solution USP post USFDA nod
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: RocheTecentriq-Avastin cocktail helps liver cancer patients live longer: Roche
    NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP ordersNPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X